U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX21838746: GSM7791881: Vero HSV1 8h rep1; Chlorocebus aethiops; OTHER
1 ILLUMINA (Illumina HiSeq 2000) run: 18.1M spots, 1.1G bases, 488.8Mb downloads

External Id: GSM7791881_r1
Submitted by: A.I. Virtanen Institute, University of Eastern Finland
Study: Herpesvirus remodel organization and function of mitochondria as infection proceeds
show Abstracthide Abstract
During the infection, viruses target mitochondria to promote viral replication. Infection-induced stress during the progression of infection leads to the regulation of antiviral defenses and mitochondrial metabolism which are opposed by counteractions of viral factors. The precise structural and functional changes that underlie how mitochondria react to the infection remain largely unclear. Our multimodal integration of advanced imaging, genomics, and metabolomics draws a comprehensive picture of time-dependent changes in mitochondria as HSV-1 infection proceeds from early to late infection. Overall design: Vero cells were infected with HSV1 and samples for GRO-Seq were collected 4 or 8 hours post infection.
Sample: Vero HSV1 8h rep1
SAMN37475142 • SRS18937117 • All experiments • All runs
Library:
Name: GSM7791881
Instrument: Illumina HiSeq 2000
Strategy: OTHER
Source: OTHER
Selection: other
Layout: SINGLE
Construction protocol: Both infected and noninfected samples of VERO cells (ATCC CCL-81) were prepared as two biological replicates. Infected sample replicates were infected independently with MOI 5. Cell nuclei were extracted post-infection at the indicated times. Cells were washed with PBS and scraped into swelling buffer containing 10 mM Tris-HCl (pH 7.5), 2 mM MgCl2, 3 mM CaCl2, 1 U/ml SUPERase-In and 1 U/ml RNAsin plus in ultrapure water (Gibco 15564-027, Invitrogen AM9530G, Sigma-Aldrich 21115-100ml, Invitrogen 10977-035, Invitrogen AM2694, Promega N2611). Cells were centrifuged at 400 x g for 10 minutes. Formed cell pellet was resuspended into swelling buffer containing 10 % glycerol and 4 U/ml SUPERase-In (ACROS ORGANICS 327255000, Invitrogen AM2694). Nuclei were extracted by incubating the cells in swelling buffer supplemented 10 % glycerol and 1% Igepal (Igepal®CA-630 I8896-50ml) for 5 minutes. Lysis buffer composted of swelling buffer, 0.5 % Igepal, 10% glycerol, 1 U/ml SUPERase-In and 1 U/ml RNAsin plus was added to the extracted nuclei. Nuclei were washed once with lysis buffer. Isolated nuclei were resuspended into freezing buffer containing 40% glycerol, 5 mM MgCl2, 0.1 mM EDTA, 50 mM Tris-HCl (pH 8.3) and 2 U/ml SUPERase-In (Invitrogen AM9260G, Gibco 15564-027 Invitrogen 15568-025) and frozen. Nuclear run-on reactions were performed for 5 minutes at 30°C in the presence of Sarkosyl and BrUTP. RNA was extracted with Trizol, DNase-treated, base-hydrolyzed and dephosphorylated with PNK. BrUTP-labeled run-on RNA was immunopurified with anti-BrdUTP-coated agarose beads and precipitated overnight. Poly(A)-tailing was followed by cDNA synthesis using complementary poly(T)-primers. Excess oligo was removed by Exonuclease I and cDNA fragments of were purified using ChIP DNA Clean & Concentrator kit. The recovered cDNA was RNAseH treated, circularized, linearized, amplified for 11-14 cycles. The final product was ran on 10% TBE gel, gel purified and cleaned-up using ChIP DNA clean & Concentrator Kit. Libraries were sequenced for 50 cycles on an Illumina HiSeq 2000 according to the manufacturer's instructions.
Runs: 1 run, 18.1M spots, 1.1G bases, 488.8Mb
Run# of Spots# of BasesSizePublished
SRR2612496318,111,6641.1G488.8Mb2024-03-18

ID:
29656410

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...